T1	Participants 115 148	polymyositis and dermatomyositis.
T2	Participants 332 389	patients with polymyositis (PM) and dermatomyositis (DM).
T3	Participants 408 444	13 patients with PM and DM completed
T4	Participants 1884 1908	patients with PM and DM.
